Article Details
Retrieved on: 2018-03-17 18:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Vanguard Group</b> Inc. grew its holdings in shares of Arbutus Biopharma by 2.7% in the 2nd quarter. <b>Vanguard Group</b> Inc. now owns 77,413 shares of the biopharmaceutical company's stock worth $279,000 after purchasing an additional 2,035 shares during the last quarter. 62.14% of the stock is ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here